-
Need to brush up on your knowledge of current treatment practices when it comes to sexually transmitted diseases (STDs)? The Centers for Disease Control and Preventions (CDCs) Division of Sexually Transmitted Diseases is offering new on-line STD education modules.
-
What is the U.S. market status for two forms of birth control, the single-rod contraceptive implant and the contraceptive sponge? Answers to these questions are provided by Marcia Diljak, spokeswoman for West Orange, NJ-based Organon, and Gene Detroyer, president and chief executive officer of Allendale (NJ) Pharmaceuticals.
-
Is your clinic seeing more women without insurance coverage whose care is now funded by Medicaid? New statistics from the New York City-based Alan Guttmacher Institute (AGI) confirm your observations: Researchers estimate that in 2003, one in five women of reproductive age were uninsured, which signals a 10% increase since 2001.
-
A check of the next patients file indicates a repeat visit for treatment of bacterial vaginosis (BV). What is your next step?
-
Facing an upward spike in its number of syphilis cases, the San Francisco Department of Public Health has spun its detection web in new directions, using a broad range of innovative Internet-based prevention interventions to stem the spread of the sexually transmitted disease (STD).
-
When it comes to emergency contraception (EC), it is an accepted standard of care in your clinic. But when it comes to the emergency department (ED) at your local hospital, is it the same story?
-
As you flip through the next patients chart, you review notes from several past visits, and all detail pain and burning on or around the vulva. According to the chart documentation, the patient states the vulvar area hurts most of the time, even when nothing is touching it.
-
The drug, approved by the Food and Drug Administration (FDA) in December, should be available on retail pharmacy shelves in mid-May, says An Phan, Pfizer corporate spokeswoman. Pricing has not been set yet on the drug, she adds.
-
Conjugated equine estrogen alone and CEE + MPA increased the risk of urinary incontinence among continent women and worsened the characteristics of urinary incontinence among symptomatic women after 1 year.
-
A meta-analysis of 19 clinical trials found that vitamin E intake greater than the recommended 400 IU/day found a statistically significant relationship between increased dosage and all-cause mortality when compared to both controls and lower doses.
